allogeneic umbilical cord blood (The Medical Pavilion Bahamas)

Allogeneic umbilical cord blood therapy is an investigational regenerative medicine approach developed by The Medical Pavilion Bahamas for the treatment of chronic neurological conditions, including stroke and spinal cord injury. The therapy utilizes donor-derived umbilical cord blood, which is rich in hematopoietic and mesenchymal stem cells, as well as various progenitor cells and bioactive factors. These cells are hypothesized to promote neural repair and functional recovery through multiple mechanisms, including the secretion of neurotrophic and angiogenic factors (paracrine signaling), modulation of the inflammatory response, and potential integration into damaged neural circuits. The therapy is typically administered via intravenous or intrathecal routes to target areas of central nervous system damage.

Other names

allogeneic cord blood treatmentallogeneic umbilical cord blood therapy